Mingshan Niu Selected Research

Kidney Neoplasms (Kidney Cancer)

3/2016

CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingshan Niu Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 04/2012
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2018
7	Glioma (Gliomas) 01/2021 - 02/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 04/2016
4	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 05/2019
4	Multiple Myeloma 01/2023 - 08/2015
3	Breast Neoplasms (Breast Cancer) 07/2023 - 01/2013
2	Lymphoma (Lymphomas) 01/2022 - 01/2020
2	Leukemia 01/2022 - 01/2018
2	Inflammation (Inflammations) 01/2022 - 12/2018
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 12/2018
2	Carcinogenesis 01/2017 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 01/2013
1	Cytokine Release Syndrome 04/2024
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Sepsis (Septicemia) 08/2020
1	Bacterial Infections (Bacterial Infection) 06/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Liver Neoplasms (Liver Cancer) 06/2019
1	Brain Neoplasms (Brain Tumor) 05/2019
1	Lung Neoplasms (Lung Cancer) 05/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2019
1	Autoimmune Diseases (Autoimmune Disease) 03/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2018
1	Weight Loss (Weight Reduction) 12/2018
1	Urticaria (Hives) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2015
4	Bortezomib (Velcade)FDA Link 01/2023 - 08/2015
4	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2020 - 01/2015
4	plumbaginIBA 09/2016 - 01/2014
2	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2018
2	Endoplasmic Reticulum Chaperone BiPIBA 03/2024 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 12/2023 - 05/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 01/2013
2	ChromatinIBA 07/2023 - 01/2023
2	IRAK1 inhibitor Jh-X-119-01IBA 01/2022 - 08/2020
2	Interleukin-1 Receptor-Associated KinasesIBA 01/2022 - 08/2020
2	piperlongumineIBA 11/2016 - 07/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 08/2015
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2016 - 08/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2024
1	Imatinib Mesylate (Gleevec)FDA Link 12/2023
1	DNA (Deoxyribonucleic Acid)IBA 07/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2023
1	EnzymesIBA 01/2023
1	statticIBA 01/2023
1	AcetylglucosamineIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	O-GlcNAc transferaseIBA 01/2023
1	N- (3- ((2- (4- amino- 1,2,5- oxadiazol- 3- yl)- 1- ethyl- 1H- imidazo(4,5- c)pyridin- 6- yl)oxy)phenyl)- 4- ((2- (4- morpholinyl)ethyl)oxy)benzamideIBA 01/2022
1	BIX 01294IBA 01/2021
1	TAK-243IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	dubermatinibIBA 12/2020
1	LipopolysaccharidesIBA 08/2020
1	Toll-Like Receptor 4IBA 08/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 06/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	AntigensIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Aurora KinasesIBA 09/2019
1	Phosphotransferases (Kinase)IBA 09/2019
1	Circulating Tumor DNAIBA 06/2019
1	osimertinibIBA 05/2019
1	AutoantibodiesIBA 03/2019
1	Inosine Triphosphate (ITP)IBA 03/2019
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 12/2018
1	Deubiquitinating EnzymesIBA 12/2018
1	Alanine Transaminase (SGPT)IBA 12/2018
1	InflammasomesIBA 12/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2018
1	Single-Chain AntibodiesIBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2017
1	caffeic acid phenethyl esterIBA 01/2017
1	Propolis (Bee Bread)IBA 01/2017
1	ibrutinibIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	HhAntag691IBA 01/2017
1	AntioxidantsIBA 01/2017
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 09/2016
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 04/2016
1	Protein Kinases (Protein Kinase)IBA 04/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2016

Therapy/Procedure

13	Therapeutics 04/2024 - 01/2013
6	Drug Therapy (Chemotherapy) 07/2023 - 10/2018
2	Cell Transplantation 01/2022 - 12/2018
2	Radiotherapy 01/2021 - 01/2020
2	Homologous Transplantation 01/2019 - 10/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2020
1	Transplantation 12/2018
1	Hematopoietic Stem Cell Transplantation 04/2016